In this report, the United States Prosthetic Joint Infections Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Prosthetic Joint Infections Treatment in these regions, from 2012 to 2022 (forecast).
United States Prosthetic Joint Infections Treatment market competition by top manufacturers/players, with Prosthetic Joint Infections Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Cempra Inc
Motif Bio Plc
Nabriva Therapeutics AG
Telephus Medical LLC
TenNor Therapeutics Ltd
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Fusidic acid
Lefamulin Acetate
MTF-101
TNP-2092
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Clinic
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Prosthetic Joint Infections Treatment Market Report 2017
1 Prosthetic Joint Infections Treatment Overview
1.1 Product Overview and Scope of Prosthetic Joint Infections Treatment
1.2 Classification of Prosthetic Joint Infections Treatment by Product Category
1.2.1 United States Prosthetic Joint Infections Treatment Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Prosthetic Joint Infections Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Fusidic acid
1.2.4 Lefamulin Acetate
1.2.5 MTF-101
1.2.6 TNP-2092
1.2.7 Others
1.3 United States Prosthetic Joint Infections Treatment Market by Application/End Users
1.3.1 United States Prosthetic Joint Infections Treatment Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 United States Prosthetic Joint Infections Treatment Market by Region
1.4.1 United States Prosthetic Joint Infections Treatment Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Prosthetic Joint Infections Treatment Status and Prospect (2012-2022)
1.4.3 Southwest Prosthetic Joint Infections Treatment Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Prosthetic Joint Infections Treatment Status and Prospect (2012-2022)
1.4.5 New England Prosthetic Joint Infections Treatment Status and Prospect (2012-2022)
1.4.6 The South Prosthetic Joint Infections Treatment Status and Prospect (2012-2022)
1.4.7 The Midwest Prosthetic Joint Infections Treatment Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Prosthetic Joint Infections Treatment (2012-2022)
1.5.1 United States Prosthetic Joint Infections Treatment Sales and Growth Rate (2012-2022)
1.5.2 United States Prosthetic Joint Infections Treatment Revenue and Growth Rate (2012-2022)
2 United States Prosthetic Joint Infections Treatment Market Competition by Players/Suppliers
2.1 United States Prosthetic Joint Infections Treatment Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Prosthetic Joint Infections Treatment Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Prosthetic Joint Infections Treatment Average Price by Players/Suppliers (2012-2017)
2.4 United States Prosthetic Joint Infections Treatment Market Competitive Situation and Trends
2.4.1 United States Prosthetic Joint Infections Treatment Market Concentration Rate
2.4.2 United States Prosthetic Joint Infections Treatment Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Prosthetic Joint Infections Treatment Manufacturing Base Distribution, Sales Area, Product Type
3 United States Prosthetic Joint Infections Treatment Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Prosthetic Joint Infections Treatment Sales and Market Share by Region (2012-2017)
3.2 United States Prosthetic Joint Infections Treatment Revenue and Market Share by Region (2012-2017)
3.3 United States Prosthetic Joint Infections Treatment Price by Region (2012-2017)
4 United States Prosthetic Joint Infections Treatment Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Prosthetic Joint Infections Treatment Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Prosthetic Joint Infections Treatment Revenue and Market Share by Type (2012-2017)
4.3 United States Prosthetic Joint Infections Treatment Price by Type (2012-2017)
4.4 United States Prosthetic Joint Infections Treatment Sales Growth Rate by Type (2012-2017)
5 United States Prosthetic Joint Infections Treatment Sales (Volume) by Application (2012-2017)
5.1 United States Prosthetic Joint Infections Treatment Sales and Market Share by Application (2012-2017)
5.2 United States Prosthetic Joint Infections Treatment Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Prosthetic Joint Infections Treatment Players/Suppliers Profiles and Sales Data
6.1 Cempra Inc
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Prosthetic Joint Infections Treatment Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Cempra Inc Prosthetic Joint Infections Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Motif Bio Plc
6.2.2 Prosthetic Joint Infections Treatment Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Motif Bio Plc Prosthetic Joint Infections Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Nabriva Therapeutics AG
6.3.2 Prosthetic Joint Infections Treatment Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Telephus Medical LLC
6.4.2 Prosthetic Joint Infections Treatment Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Telephus Medical LLC Prosthetic Joint Infections Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 TenNor Therapeutics Ltd
6.5.2 Prosthetic Joint Infections Treatment Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
...
7 Prosthetic Joint Infections Treatment Manufacturing Cost Analysis
7.1 Prosthetic Joint Infections Treatment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Prosthetic Joint Infections Treatment
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Prosthetic Joint Infections Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Prosthetic Joint Infections Treatment Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Prosthetic Joint Infections Treatment Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Prosthetic Joint Infections Treatment Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Prosthetic Joint Infections Treatment Sales Volume Forecast by Type (2017-2022)
11.3 United States Prosthetic Joint Infections Treatment Sales Volume Forecast by Application (2017-2022)
11.4 United States Prosthetic Joint Infections Treatment Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Prosthetic Joint Infections Treatment
Figure United States Prosthetic Joint Infections Treatment Market Size (K Pcs) by Type (2012-2022)
Figure United States Prosthetic Joint Infections Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure Fusidic acid Product Picture
Figure Lefamulin Acetate Product Picture
Figure MTF-101 Product Picture
Figure TNP-2092 Product Picture
Figure Others Product Picture
Figure United States Prosthetic Joint Infections Treatment Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Prosthetic Joint Infections Treatment by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Prosthetic Joint Infections Treatment Market Size (Million USD) by Region (2012-2022)
Figure The West Prosthetic Joint Infections Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Prosthetic Joint Infections Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Prosthetic Joint Infections Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Prosthetic Joint Infections Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Prosthetic Joint Infections Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Prosthetic Joint Infections Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Prosthetic Joint Infections Treatment Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Prosthetic Joint Infections Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Prosthetic Joint Infections Treatment Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Prosthetic Joint Infections Treatment Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Prosthetic Joint Infections Treatment Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Prosthetic Joint Infections Treatment Sales Share by Players/Suppliers
Figure 2017 United States Prosthetic Joint Infections Treatment Sales Share by Players/Suppliers
Figure United States Prosthetic Joint Infections Treatment Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Prosthetic Joint Infections Treatment Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Prosthetic Joint Infections Treatment Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Prosthetic Joint Infections Treatment Revenue Share by Players/Suppliers
Figure 2017 United States Prosthetic Joint Infections Treatment Revenue Share by Players/Suppliers
Table United States Market Prosthetic Joint Infections Treatment Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Prosthetic Joint Infections Treatment Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Prosthetic Joint Infections Treatment Market Share of Top 3 Players/Suppliers
Figure United States Prosthetic Joint Infections Treatment Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Prosthetic Joint Infections Treatment Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Prosthetic Joint Infections Treatment Product Category
Table United States Prosthetic Joint Infections Treatment Sales (K Pcs) by Region (2012-2017)
Table United States Prosthetic Joint Infections Treatment Sales Share by Region (2012-2017)
Figure United States Prosthetic Joint Infections Treatment Sales Share by Region (2012-2017)
Figure United States Prosthetic Joint Infections Treatment Sales Market Share by Region in 2016
Table United States Prosthetic Joint Infections Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Prosthetic Joint Infections Treatment Revenue Share by Region (2012-2017)
Figure United States Prosthetic Joint Infections Treatment Revenue Market Share by Region (2012-2017)
Figure United States Prosthetic Joint Infections Treatment Revenue Market Share by Region in 2016
Table United States Prosthetic Joint Infections Treatment Price (USD/Pcs) by Region (2012-2017)
Table United States Prosthetic Joint Infections Treatment Sales (K Pcs) by Type (2012-2017)
Table United States Prosthetic Joint Infections Treatment Sales Share by Type (2012-2017)
Figure United States Prosthetic Joint Infections Treatment Sales Share by Type (2012-2017)
Figure United States Prosthetic Joint Infections Treatment Sales Market Share by Type in 2016
Table United States Prosthetic Joint Infections Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Prosthetic Joint Infections Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Prosthetic Joint Infections Treatment by Type (2012-2017)
Figure Revenue Market Share of Prosthetic Joint Infections Treatment by Type in 2016
Table United States Prosthetic Joint Infections Treatment Price (USD/Pcs) by Types (2012-2017)
Figure United States Prosthetic Joint Infections Treatment Sales Growth Rate by Type (2012-2017)
Table United States Prosthetic Joint Infections Treatment Sales (K Pcs) by Application (2012-2017)
Table United States Prosthetic Joint Infections Treatment Sales Market Share by Application (2012-2017)
Figure United States Prosthetic Joint Infections Treatment Sales Market Share by Application (2012-2017)
Figure United States Prosthetic Joint Infections Treatment Sales Market Share by Application in 2016
Table United States Prosthetic Joint Infections Treatment Sales Growth Rate by Application (2012-2017)
Figure United States Prosthetic Joint Infections Treatment Sales Growth Rate by Application (2012-2017)
Table Cempra Inc Basic Information List
Table Cempra Inc Prosthetic Joint Infections Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cempra Inc Prosthetic Joint Infections Treatment Sales Growth Rate (2012-2017)
Figure Cempra Inc Prosthetic Joint Infections Treatment Sales Market Share in United States (2012-2017)
Figure Cempra Inc Prosthetic Joint Infections Treatment Revenue Market Share in United States (2012-2017)
Table Motif Bio Plc Basic Information List
Table Motif Bio Plc Prosthetic Joint Infections Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Motif Bio Plc Prosthetic Joint Infections Treatment Sales Growth Rate (2012-2017)
Figure Motif Bio Plc Prosthetic Joint Infections Treatment Sales Market Share in United States (2012-2017)
Figure Motif Bio Plc Prosthetic Joint Infections Treatment Revenue Market Share in United States (2012-2017)
Table Nabriva Therapeutics AG Basic Information List
Table Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Sales Growth Rate (2012-2017)
Figure Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Sales Market Share in United States (2012-2017)
Figure Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Revenue Market Share in United States (2012-2017)
Table Telephus Medical LLC Basic Information List
Table Telephus Medical LLC Prosthetic Joint Infections Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Telephus Medical LLC Prosthetic Joint Infections Treatment Sales Growth Rate (2012-2017)
Figure Telephus Medical LLC Prosthetic Joint Infections Treatment Sales Market Share in United States (2012-2017)
Figure Telephus Medical LLC Prosthetic Joint Infections Treatment Revenue Market Share in United States (2012-2017)
Table TenNor Therapeutics Ltd Basic Information List
Table TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Sales Growth Rate (2012-2017)
Figure TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Sales Market Share in United States (2012-2017)
Figure TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prosthetic Joint Infections Treatment
Figure Manufacturing Process Analysis of Prosthetic Joint Infections Treatment
Figure Prosthetic Joint Infections Treatment Industrial Chain Analysis
Table Raw Materials Sources of Prosthetic Joint Infections Treatment Major Players/Suppliers in 2016
Table Major Buyers of Prosthetic Joint Infections Treatment
Table Distributors/Traders List
Figure United States Prosthetic Joint Infections Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Prosthetic Joint Infections Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Prosthetic Joint Infections Treatment Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Prosthetic Joint Infections Treatment Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Prosthetic Joint Infections Treatment Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Prosthetic Joint Infections Treatment Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Prosthetic Joint Infections Treatment Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Prosthetic Joint Infections Treatment Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Prosthetic Joint Infections Treatment Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Prosthetic Joint Infections Treatment Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Prosthetic Joint Infections Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Prosthetic Joint Infections Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Prosthetic Joint Infections Treatment Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
